Content Topics

AI, Compute & Quantum 15

View All

A bold and timely bet: the U.S. Government invests in quantum computing

By Matthew Ocko, James Hardiman, Dr. Prineha Narang

How the quantum race will be won on the factory floor

By Dr. Prineha Narang

A new pinnacle in fault tolerant quantum computing

By Dr. Prineha Narang

Quantum’s super position

By Matthew Ocko, James Hardiman, Dr. Prineha Narang

Computational Bio & Chem 32

View All

Deep Tech Opportunities Report

Deep Tech Opportunity: There’s an exciting new way to put protein-like drugs inside cells

Deep Tech Opportunities Report

Deep Tech Opportunity: It’s time to develop better drugs to treat anxiety

Deep Tech Opportunities Report

Deep Tech Opportunity: It’s time to overhaul regulation and reimbursement for one-and-done treatments

Deep Tech Opportunities Report

Deep Tech Opportunity: Third-generation gene therapy companies are advancing toward cures for major diseases that can be treated in no other way

Cybersecurity, Security, & Defense 19

View All

Deep Tech Opportunities Report

Deep Tech Opportunity: Startup-built technologies are bringing us new ways to dominate in the air and in space

Neutralizing the swarm: Fortem cements its position as the go-to for drone defense

By Matthew Ocko

How Fortem is helping the U.S. and its allies get ahead of the drone threat

By Matthew Ocko, Matt O'Connell

Human identity needs a Zero Trust moment

Energy & Climate 78

View All

Fervo IPO

By Dr. Rachel Slaybaugh, Zachary Bogue

Deep Tech Opportunities Report

Deep Tech Opportunity: Water offsets are giving big water users a responsible way to keep growing

Deep Tech Opportunities Report

DCVC DTOR 2025: One overlooked source of clean water is polluted water

Deep Tech Opportunities Report

DCVC DTOR 2025: For the environment and for our health, we must learn to produce more food, more efficiently

Finance & Insurance 4

View All

A new precision power market

DCVC proud to back ElectronX in its quest to build the first-ever direct-access regulated derivatives exchange for the electric power markets

Deep Tech Opportunities Report

Cryptography for the real world

StarkWare Raises $30M Series A to Build Post-Quantum Secure Blockchain

By Matthew Ocko

Industrial Transformation & Advanced Manufacturing 34

View All

Deep Tech Opportunities Report

DCVC DTOR 2025: One overlooked source of clean water is polluted water

Deep Tech Opportunities Report

DCVC DTOR 2025: Robots should be backward-compatible with the real world

Fulfil’s robot revolution comes to Whole Foods

Company Profile

Flexible Power for an inflexible grid: Why DCVC backed Mainspring Energy

Next-Gen Agriculture 17

View All

Deep Tech Opportunities Report

DCVC DTOR 2025: For the environment and for our health, we must learn to produce more food, more efficiently

Halter’s invisible fencing drives an inevitable shift in ranching

By Spencer Punter

Company Profile

Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners

By Dr. Justin Kern

Deep Tech Opportunities Report

DCVC DTOR 2024: Drop-in replacements are a way to start decarbonizing the economy, now

Space 10

View All

Deep Tech Opportunities Report

Deep Tech Opportunity: Startup-built technologies are bringing us new ways to dominate in the air and in space

DCVC anchors $150 million in financing for Impulse Space to deliver precise, fast, and affordable maneuverability of satellites within and between orbits

By Matthew Ocko, Matt O'Connell

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC Announcements

DCVC Welcomes 2022

TechBio 11

View All

Kanvas makes the microbiome druggable—and the implications are massive

By Jason Pontin

Deep Tech Opportunities Report

Deep Tech Opportunity: TechBio companies are using data to rethink how we develop new medical treatments

Proxima raises $80M in seed financing, led by DCVC, to reprogram protein-protein interactions

By Jason Pontin

Noetik’s partnership with GSK puts dollar signs on the AI licensing business model in TechBio

By James Hardiman

TechMed 22

View All

Valar’s AI-derived biomarker is a game-changer for treating pancreatic cancer

By James Hardiman

Remedy’s AI-powered robot supports world’s first remote neurointervention

By James Hardiman

Proprio’s latest FDA approval clears the way for better, AI-driven surgery

Proprio's Physical AI at the 2025 JPM Healthcare Conference